These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 28611044

  • 21. GITR Activation Positively Regulates Immune Responses against Toxoplasma gondii.
    Costa FR, Mota CM, Santiago FM, Silva MV, Ferreira MD, Fonseca DM, Silva JS, Mineo JR, Mineo TW.
    PLoS One; 2016; 11(3):e0152622. PubMed ID: 27027302
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.
    Mitsui J, Nishikawa H, Muraoka D, Wang L, Noguchi T, Sato E, Kondo S, Allison JP, Sakaguchi S, Old LJ, Kato T, Shiku H.
    Clin Cancer Res; 2010 May 15; 16(10):2781-91. PubMed ID: 20460483
    [Abstract] [Full Text] [Related]

  • 24. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R, Bistoni O, Alunno A, Petrillo MG, Ronchetti S, Sportoletti P, Bocci EB, Nocentini G, Gerli R, Riccardi C.
    Eur J Immunol; 2011 Aug 15; 41(8):2269-78. PubMed ID: 21557210
    [Abstract] [Full Text] [Related]

  • 25. Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells.
    Kim IK, Kim BS, Koh CH, Seok JW, Park JS, Shin KS, Bae EA, Lee GE, Jeon H, Cho J, Jung Y, Han D, Kwon BS, Lee HY, Chung Y, Kang CY.
    Nat Med; 2015 Sep 15; 21(9):1010-7. PubMed ID: 26280119
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Mature B cells are critical to T-cell-mediated tumor immunity induced by an agonist anti-GITR monoclonal antibody.
    Zhou P, Qiu J, L'Italien L, Gu D, Hodges D, Chao CC, Schebye XM.
    J Immunother; 2010 Oct 15; 33(8):789-97. PubMed ID: 20842058
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Murinization and H Chain Isotype Matching of the Anti-GITR Antibody DTA-1 Reduces Immunogenicity-Mediated Anaphylaxis in C57BL/6 Mice.
    Belmar NA, Chan SW, Fox MI, Samayoa JA, Stickler MM, Tran NN, Akamatsu Y, Hollenbaugh D, Harding FA, Alvarez HM.
    J Immunol; 2017 Jun 01; 198(11):4502-4512. PubMed ID: 28446565
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Anaphylaxis caused by repetitive doses of a GITR agonist monoclonal antibody in mice.
    Murphy JT, Burey AP, Beebe AM, Gu D, Presta LG, Merghoub T, Wolchok JD.
    Blood; 2014 Apr 03; 123(14):2172-80. PubMed ID: 24558202
    [Abstract] [Full Text] [Related]

  • 35. GITR subverts Foxp3(+) Tregs to boost Th9 immunity through regulation of histone acetylation.
    Xiao X, Shi X, Fan Y, Zhang X, Wu M, Lan P, Minze L, Fu YX, Ghobrial RM, Liu W, Li XC.
    Nat Commun; 2015 Sep 14; 6():8266. PubMed ID: 26365427
    [Abstract] [Full Text] [Related]

  • 36. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
    Nishioka T, Nishida E, Iida R, Morita A, Shimizu J.
    Immunol Lett; 2008 Dec 22; 121(2):97-104. PubMed ID: 18930767
    [Abstract] [Full Text] [Related]

  • 37. Glucocorticoid-induced tumour necrosis factor receptor family-related receptor signalling exacerbates hapten-induced colitis by CD4+ T cells.
    Lee SK, Choi BK, Kim YH, Kang WJ, Kim KH, Sakaguchi S, Suh JH, Kim TY, Kwon BS.
    Immunology; 2006 Dec 22; 119(4):479-87. PubMed ID: 17177830
    [Abstract] [Full Text] [Related]

  • 38. Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment.
    Ji Y, Madrasi K, Knee DA, Gruenbaum L, Apgar JF, Burke JM, Gomes B.
    CPT Pharmacometrics Syst Pharmacol; 2023 Mar 22; 12(3):413-424. PubMed ID: 36710369
    [Abstract] [Full Text] [Related]

  • 39. GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells.
    Rakké YS, Campos Carrascosa L, van Beek AA, de Ruiter V, van Gemerden RS, Doukas M, Doornebosch PG, Vermaas M, Ter Borg S, van der Harst E, Coene PPLO, Kliffen M, Grünhagen DJ, Verhoef C, IJzermans JNM, Kwekkeboom J, Sprengers D.
    Cell Mol Gastroenterol Hepatol; 2023 Mar 22; 15(1):77-97. PubMed ID: 36155259
    [Abstract] [Full Text] [Related]

  • 40. Rationale for anti-GITR cancer immunotherapy.
    Knee DA, Hewes B, Brogdon JL.
    Eur J Cancer; 2016 Nov 22; 67():1-10. PubMed ID: 27591414
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.